Ascentage Pharma Group International (HK:6855) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ascentage Pharma Group International has announced the members of its board of directors, highlighting a diverse team led by Executive Director Dr. YANG Dajun. The board comprises both non-executive and independent non-executive directors with significant expertise in the industry. This leadership structure is poised to guide the company in its strategic endeavors.
For further insights into HK:6855 stock, check out TipRanks’ Stock Analysis page.